Tarceva 100mg TABLET
By Tarceva
Rx
10 Tablet in a Strip

Composition
Erlotinib(100mg)

Manufacturer - Roche Products India Pvt Ltd
1503, 15th Floor, 'The Capital', Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Expires on or after
September, 2025

liver
When considering Tarceva 100mg TABLET for use, it is important to exercise caution if you have liver disease. Adjusting the dosage of Tarceva 100mg TABLET may be necessary in such cases, so it is crucial to consult your doctor for proper guidance. While there is limited information regarding the use of Tarceva 100mg TABLET in patients with liver issues, no dose adjustment is typically advised for those with mild to moderate liver disease. It's essential to prioritize your liver health and seek medical advice to ensure the safe and effective use of Tarceva 100mg TABLET.

kidney
Tarceva 100mg TABLET is safe for patients with kidney disease. No dose adjustment is needed. Avoid in severe kidney disease.

alcohol
Consult your doctor when consuming alcohol with Tarceva 100mg TABLET.

driving
It is not clearly established if Tarceva 100mg TABLET affects driving. Refrain from driving if you have symptoms that impair focus and reaction time while taking this medication.

pregnancy
Tarceva 100mg TABLET is not safe to use during pregnancy due to known risks to the baby's development. It may be considered in life-threatening situations only after a doctor's assessment of benefits versus risks. Kindly seek medical advice before use.

breastfeeding
Tarceva 100mg TABLET is likely unsafe during breastfeeding, as limited human data indicates it may pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | Quinazoline Derivative |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹35450
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024